FDA Approves Daraxonrasib Breakthrough Pancreatic Cancer Drug
FDA Approves Daraxonrasib: A Landmark Moment in Pancreatic Cancer Treatment On August 26, 2026, the U.S. Food and Drug Administration
Read more
Medical
FDA Approves First RAS-Targeted Drug for Pancreatic Cancer
FDA Approves First RAS-Targeted Drug for Pancreatic Cancer On August 26, 2026, the U.S. Food and Drug Administration granted approval
Read more
Wearable Ultrasound Patch Breakthrough Transforms Sleep Therapy
Sleep disorders affect millions worldwide, and the search for effective, non-invasive treatments has taken a remarkable leap forward. Researchers at
Read more